Explanatory Note.
The Reporting Persons previously filed an original Schedule 13D in respect of the common stock, par value $0.001 per share (the “Common Stock”), of Beam Global, a Nevada corporation (the “Issuer”), on July 8, 2022 (the “Original Schedule 13D”). This Amendment No. 3 amends the Original Schedule 13D, as amended by Amendment No. 2 filed on February 23, 2023 (the “Schedule 13D”) and Amendment No. 1 filed on December 23, 2022, and is being filed to reflect that the Reporting Persons now beneficially own 1,045,115 shares, which approximates to 9.71%, of Common Stock. Capitalized terms used but not defined herein shall have the meaning set forth in the Original Schedule 13D. Except as set forth herein, the Original Schedule 13D is unmodified and remains in full force and effect. Each capitalized term used but not defined herein has the meaning ascribed to such term in the Original Schedule 13D.
Item 3. Source and Amount of Funds or Other Consideration.
On March 4, 2021 (the “Closing Date”), the Issuer completed the transactions contemplated by the Asset Purchase Agreement, dated as of February 16, 2022 (the “Purchase Agreement”), by and between the Issuer and All Cell Technologies LLC, an Illinois limited liability company (“All Cell”). At the Closing, (i) All Cell transferred to the Issuer all right, title and interest in, to and under the Purchased Assets (as defined in the Purchase Agreement) and (ii) the Issuer issued to All Cell 1,055,000 shares of Common Stock (the “Shares”).
Additionally, in accordance with the terms of the Purchase Agreement, on April 24, 2023, the Issuer issued 446,815 additional shares of Common Stock to Townsend AC based on the amount that Cumulative Revenue (as defined in the Purchase Agreement) exceeded $7,500,000 in fiscal year 2022. (The number of additional shares issuable to the Reporting Persons pursuant to the foregoing provisions of the Purchase Agreement could not exceed a maximum number of shares of Common Stock representing 19.99% of the issued and outstanding number of shares of Common Stock as of February 16, 2022.) The transactions contemplated by the Purchase Agreement are referred to herein as the “Transaction.” Following the Closing Date, All Cell changed its name to “Townsend AC, LLC.”
The closing of the transactions underlying the Purchase Agreement occurred on or around March 1, 2022, subject to customary closing conditions. All Beam Common Stock issued to Townsend AC, LLC to satisfy the Closing Consideration and any Earnout Consideration was issued in a private placement and is subject to transfer restrictions under the Securities Act of 1933, as amended. Beam has agreed to file a resale registration statement with the SEC to register the resale of up to $10 million of the Common Stock issued to Townsend AC, LLC for the Closing Consideration. Pursuant to the terms of the Purchase Agreement, Townsend AC, LLC agreed not to sell shares of Beam Common Stock (i) in an amount greater than four percent (4%) of the average weekly volume of shares of Beam Common Stock during any trading week and (ii) on more than three days in any week and (iii) in an amount greater than ten percent (10%) of the average daily trading volume on any trading day.
The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the Purchase Agreement, which is filed as an exhibit hereto and incorporated by reference herein.
Item 4. Purpose of Transaction.
Item 4 of the Schedule 13D is hereby amended and restated in its entirety as follows:
The information regarding the Transaction set forth in Item 3 is incorporated into this Item 4 by reference.
The Reporting Persons acquired the securities reported herein in connection with the Transaction. From October 4, 2022, to May 18, 2023, Townsend AC completed the Sales in which it disposed a total of 456,700 shares of Common Stock and received a total of 446,815 shares of Common Stock through Earnouts of the Transaction referenced above in Item 3. The Reporting Persons hold such securities for investment purposes and intend to review their investments in the Issuer on a continuing basis. Except as described in this Statement, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D, although, subject to the agreements described herein and various factors, including but not limited to the Issuer’s financial position and strategic direction, price levels of the Common Stock, conditions in the securities markets, various laws and regulations applicable to the Issuer and